Vol. 3 | Issue 4 | November 2026 | Pages 18-25

Homeopathy in Breast Cancer Supportive Care: A Critical Review of Clinical Evidence, Safety and Methodological Challenges

Avil Kumar Jain*, Gaurav Nagar

DOI: https://doi.org/10.47857/irjmeds.2026.v03i04.086

Share Email

* Corresponding author

Keywords

  • Breast Cancer
  • Homeopathy
  • Integrative Oncology
  • Supportive Care

Abstract

Breast cancer care is complicated by its severe effects on the patients' physical, psychological and social functioning. Hence, supportive care has emerged as an essential adjuvant component of holistic cancer therapy. Homoeopathy for menopausal symptoms, hot flashes, exhaustion, joint pain, skin responses related to radiation and postoperative problems has been studied as supplementary medicine in the care of breast cancer–related symptoms. This study objectively assesses the existing clinical data for the many uses of homoeopathy, safety and methodological constraints in supportive treatment of breast cancer. A narrative, descriptive evaluation of relevant clinical trials, observational studies, systematic reviews and integrative oncology guidelines were examined in this study. certain studies indicated positive findings on postoperative measures and certain patient-reported symptoms. By contrast, randomised placebocontrolled trials have shown little or limited advantage of homoeopathy above placebo, especially in relation to the menopausal symptoms of endocrine treatment. Evidence for aromatase inhibitor-associated arthralgia, radiationinduced skin toxicity and postoperative recovery is preliminary and restricted by small sample size and methodological heterogeneity. Furthermore, systematic cancer reviews find considerable variation in trial design, treatment schedules and outcome measures and little adverse-event reporting. To summarise, current research does not suggest that homoeopathy is beneficial when added to therapeutic treatment of breast cancer. Larger and better-designed clinical studies with validated treatments and outcomes and with long-term safety evaluation are needed to explain the real role which homoeopathy may play in supportive care, as an adjuvant but not an alternative to cancer therapy, standard or otherwise.